Home Healthcare Pharmaceuticals Long-Acting Injectables (LAIs) Market

Long-Acting Injectables (LAIs) Market Size, Share & Trends Analysis Report By Molecule Type (Small Molecules, Biologics), By Route of Administration (Intramuscular, Subcutaneous), By Therapeutic Area (Central Nervous System Disorders, Infectious Diseases, Metabolic & Endocrine Disorders, Oncology, Autoimmune & Inflammatory Diseases, Other Therapeutic Areas), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, Specialty Pharmacies) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 14, 2026 | Author: Dhanashri B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Long-Acting Injectables (LAIs) Market, By Molecule Type 2022-2034 (USD MILLION/ Units)
    1. Small Molecules
    2. Biologics
  2. Long-Acting Injectables (LAIs) Market, By Route of Administration 2022-2034 (USD MILLION/ Units)
    1. Intramuscular
    2. Subcutaneous
  3. Long-Acting Injectables (LAIs) Market, By Therapeutic Area 2022-2034 (USD MILLION/ Units)
    1. Central Nervous System Disorders
    2. Infectious Diseases
    3. Metabolic & Endocrine Disorders
    4. Oncology
    5. Autoimmune & Inflammatory Diseases
    6. Other Therapeutic Areas
  4. Long-Acting Injectables (LAIs) Market, By Distribution Channel 2022-2034 (USD MILLION/ Units)
    1. Hospital Pharmacies
    2. Drug Stores & Retail Pharmacies
    3. Specialty Pharmacies
  5. Regional Long-Acting Injectables (LAIs) Market
    1. North America
      1. North America Long-Acting Injectables (LAIs) Market By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      2. North America Long-Acting Injectables (LAIs) Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      3. North America Long-Acting Injectables (LAIs) Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      4. North America Long-Acting Injectables (LAIs) Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
      5. U.S.
        1. Small Molecules
        2. Biologics
        3. Intramuscular
        4. Subcutaneous
        5. Central Nervous System Disorders
        6. Infectious Diseases
        7. Metabolic & Endocrine Disorders
        8. Oncology
        9. Autoimmune & Inflammatory Diseases
        10. Other Therapeutic Areas
        11. Hospital Pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Specialty Pharmacies
      6. Canada
        1. Small Molecules
        2. Biologics
        3. Intramuscular
        4. Subcutaneous
        5. Central Nervous System Disorders
        6. Infectious Diseases
        7. Metabolic & Endocrine Disorders
        8. Oncology
        9. Autoimmune & Inflammatory Diseases
        10. Other Therapeutic Areas
        11. Hospital Pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Specialty Pharmacies
    2. Europe
      1. Europe Long-Acting Injectables (LAIs) Market By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      2. Europe Long-Acting Injectables (LAIs) Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      3. Europe Long-Acting Injectables (LAIs) Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      4. Europe Long-Acting Injectables (LAIs) Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
      5. U.K.
        1. Small Molecules
        2. Biologics
        3. Intramuscular
        4. Subcutaneous
        5. Central Nervous System Disorders
        6. Infectious Diseases
        7. Metabolic & Endocrine Disorders
        8. Oncology
        9. Autoimmune & Inflammatory Diseases
        10. Other Therapeutic Areas
        11. Hospital Pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Specialty Pharmacies
      6. Germany
        1. Small Molecules
        2. Biologics
        3. Intramuscular
        4. Subcutaneous
        5. Central Nervous System Disorders
        6. Infectious Diseases
        7. Metabolic & Endocrine Disorders
        8. Oncology
        9. Autoimmune & Inflammatory Diseases
        10. Other Therapeutic Areas
        11. Hospital Pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Specialty Pharmacies
      7. France
        1. Small Molecules
        2. Biologics
        3. Intramuscular
        4. Subcutaneous
        5. Central Nervous System Disorders
        6. Infectious Diseases
        7. Metabolic & Endocrine Disorders
        8. Oncology
        9. Autoimmune & Inflammatory Diseases
        10. Other Therapeutic Areas
        11. Hospital Pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Specialty Pharmacies
      8. Spain
        1. Small Molecules
        2. Biologics
        3. Intramuscular
        4. Subcutaneous
        5. Central Nervous System Disorders
        6. Infectious Diseases
        7. Metabolic & Endocrine Disorders
        8. Oncology
        9. Autoimmune & Inflammatory Diseases
        10. Other Therapeutic Areas
        11. Hospital Pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Specialty Pharmacies
      9. Italy
        1. Small Molecules
        2. Biologics
        3. Intramuscular
        4. Subcutaneous
        5. Central Nervous System Disorders
        6. Infectious Diseases
        7. Metabolic & Endocrine Disorders
        8. Oncology
        9. Autoimmune & Inflammatory Diseases
        10. Other Therapeutic Areas
        11. Hospital Pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Specialty Pharmacies
      10. Russia
        1. Small Molecules
        2. Biologics
        3. Intramuscular
        4. Subcutaneous
        5. Central Nervous System Disorders
        6. Infectious Diseases
        7. Metabolic & Endocrine Disorders
        8. Oncology
        9. Autoimmune & Inflammatory Diseases
        10. Other Therapeutic Areas
        11. Hospital Pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Specialty Pharmacies
      11. Nordic
        1. Small Molecules
        2. Biologics
        3. Intramuscular
        4. Subcutaneous
        5. Central Nervous System Disorders
        6. Infectious Diseases
        7. Metabolic & Endocrine Disorders
        8. Oncology
        9. Autoimmune & Inflammatory Diseases
        10. Other Therapeutic Areas
        11. Hospital Pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Specialty Pharmacies
      12. Benelux
        1. Small Molecules
        2. Biologics
        3. Intramuscular
        4. Subcutaneous
        5. Central Nervous System Disorders
        6. Infectious Diseases
        7. Metabolic & Endocrine Disorders
        8. Oncology
        9. Autoimmune & Inflammatory Diseases
        10. Other Therapeutic Areas
        11. Hospital Pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Specialty Pharmacies
      13. Rest of Europe
        1. Small Molecules
        2. Biologics
        3. Intramuscular
        4. Subcutaneous
        5. Central Nervous System Disorders
        6. Infectious Diseases
        7. Metabolic & Endocrine Disorders
        8. Oncology
        9. Autoimmune & Inflammatory Diseases
        10. Other Therapeutic Areas
        11. Hospital Pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Specialty Pharmacies
    3. APAC
      1. APAC Long-Acting Injectables (LAIs) Market By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      2. APAC Long-Acting Injectables (LAIs) Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      3. APAC Long-Acting Injectables (LAIs) Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      4. APAC Long-Acting Injectables (LAIs) Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
      5. China
        1. Small Molecules
        2. Biologics
        3. Intramuscular
        4. Subcutaneous
        5. Central Nervous System Disorders
        6. Infectious Diseases
        7. Metabolic & Endocrine Disorders
        8. Oncology
        9. Autoimmune & Inflammatory Diseases
        10. Other Therapeutic Areas
        11. Hospital Pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Specialty Pharmacies
      6. Korea
        1. Small Molecules
        2. Biologics
        3. Intramuscular
        4. Subcutaneous
        5. Central Nervous System Disorders
        6. Infectious Diseases
        7. Metabolic & Endocrine Disorders
        8. Oncology
        9. Autoimmune & Inflammatory Diseases
        10. Other Therapeutic Areas
        11. Hospital Pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Specialty Pharmacies
      7. Japan
        1. Small Molecules
        2. Biologics
        3. Intramuscular
        4. Subcutaneous
        5. Central Nervous System Disorders
        6. Infectious Diseases
        7. Metabolic & Endocrine Disorders
        8. Oncology
        9. Autoimmune & Inflammatory Diseases
        10. Other Therapeutic Areas
        11. Hospital Pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Specialty Pharmacies
      8. India
        1. Small Molecules
        2. Biologics
        3. Intramuscular
        4. Subcutaneous
        5. Central Nervous System Disorders
        6. Infectious Diseases
        7. Metabolic & Endocrine Disorders
        8. Oncology
        9. Autoimmune & Inflammatory Diseases
        10. Other Therapeutic Areas
        11. Hospital Pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Specialty Pharmacies
      9. Australia
        1. Small Molecules
        2. Biologics
        3. Intramuscular
        4. Subcutaneous
        5. Central Nervous System Disorders
        6. Infectious Diseases
        7. Metabolic & Endocrine Disorders
        8. Oncology
        9. Autoimmune & Inflammatory Diseases
        10. Other Therapeutic Areas
        11. Hospital Pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Specialty Pharmacies
      10. Taiwan
        1. Small Molecules
        2. Biologics
        3. Intramuscular
        4. Subcutaneous
        5. Central Nervous System Disorders
        6. Infectious Diseases
        7. Metabolic & Endocrine Disorders
        8. Oncology
        9. Autoimmune & Inflammatory Diseases
        10. Other Therapeutic Areas
        11. Hospital Pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Specialty Pharmacies
      11. South East Asia
        1. Small Molecules
        2. Biologics
        3. Intramuscular
        4. Subcutaneous
        5. Central Nervous System Disorders
        6. Infectious Diseases
        7. Metabolic & Endocrine Disorders
        8. Oncology
        9. Autoimmune & Inflammatory Diseases
        10. Other Therapeutic Areas
        11. Hospital Pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Specialty Pharmacies
      12. Rest of Asia-Pacific
        1. Small Molecules
        2. Biologics
        3. Intramuscular
        4. Subcutaneous
        5. Central Nervous System Disorders
        6. Infectious Diseases
        7. Metabolic & Endocrine Disorders
        8. Oncology
        9. Autoimmune & Inflammatory Diseases
        10. Other Therapeutic Areas
        11. Hospital Pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Specialty Pharmacies
    4. Middle East and Africa
      1. Middle East and Africa Long-Acting Injectables (LAIs) Market By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      2. Middle East and Africa Long-Acting Injectables (LAIs) Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      3. Middle East and Africa Long-Acting Injectables (LAIs) Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      4. Middle East and Africa Long-Acting Injectables (LAIs) Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
      5. UAE
        1. Small Molecules
        2. Biologics
        3. Intramuscular
        4. Subcutaneous
        5. Central Nervous System Disorders
        6. Infectious Diseases
        7. Metabolic & Endocrine Disorders
        8. Oncology
        9. Autoimmune & Inflammatory Diseases
        10. Other Therapeutic Areas
        11. Hospital Pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Specialty Pharmacies
      6. Turkey
        1. Small Molecules
        2. Biologics
        3. Intramuscular
        4. Subcutaneous
        5. Central Nervous System Disorders
        6. Infectious Diseases
        7. Metabolic & Endocrine Disorders
        8. Oncology
        9. Autoimmune & Inflammatory Diseases
        10. Other Therapeutic Areas
        11. Hospital Pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Specialty Pharmacies
      7. Saudi Arabia
        1. Small Molecules
        2. Biologics
        3. Intramuscular
        4. Subcutaneous
        5. Central Nervous System Disorders
        6. Infectious Diseases
        7. Metabolic & Endocrine Disorders
        8. Oncology
        9. Autoimmune & Inflammatory Diseases
        10. Other Therapeutic Areas
        11. Hospital Pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Specialty Pharmacies
      8. South Africa
        1. Small Molecules
        2. Biologics
        3. Intramuscular
        4. Subcutaneous
        5. Central Nervous System Disorders
        6. Infectious Diseases
        7. Metabolic & Endocrine Disorders
        8. Oncology
        9. Autoimmune & Inflammatory Diseases
        10. Other Therapeutic Areas
        11. Hospital Pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Specialty Pharmacies
      9. Egypt
        1. Small Molecules
        2. Biologics
        3. Intramuscular
        4. Subcutaneous
        5. Central Nervous System Disorders
        6. Infectious Diseases
        7. Metabolic & Endocrine Disorders
        8. Oncology
        9. Autoimmune & Inflammatory Diseases
        10. Other Therapeutic Areas
        11. Hospital Pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Specialty Pharmacies
      10. Nigeria
        1. Small Molecules
        2. Biologics
        3. Intramuscular
        4. Subcutaneous
        5. Central Nervous System Disorders
        6. Infectious Diseases
        7. Metabolic & Endocrine Disorders
        8. Oncology
        9. Autoimmune & Inflammatory Diseases
        10. Other Therapeutic Areas
        11. Hospital Pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Specialty Pharmacies
      11. Rest of MEA
        1. Small Molecules
        2. Biologics
        3. Intramuscular
        4. Subcutaneous
        5. Central Nervous System Disorders
        6. Infectious Diseases
        7. Metabolic & Endocrine Disorders
        8. Oncology
        9. Autoimmune & Inflammatory Diseases
        10. Other Therapeutic Areas
        11. Hospital Pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Specialty Pharmacies
    5. LATAM
      1. LATAM Long-Acting Injectables (LAIs) Market By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologics
      2. LATAM Long-Acting Injectables (LAIs) Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intramuscular
        2. Subcutaneous
      3. LATAM Long-Acting Injectables (LAIs) Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Central Nervous System Disorders
        2. Infectious Diseases
        3. Metabolic & Endocrine Disorders
        4. Oncology
        5. Autoimmune & Inflammatory Diseases
        6. Other Therapeutic Areas
      4. LATAM Long-Acting Injectables (LAIs) Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
      5. Brazil
        1. Small Molecules
        2. Biologics
        3. Intramuscular
        4. Subcutaneous
        5. Central Nervous System Disorders
        6. Infectious Diseases
        7. Metabolic & Endocrine Disorders
        8. Oncology
        9. Autoimmune & Inflammatory Diseases
        10. Other Therapeutic Areas
        11. Hospital Pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Specialty Pharmacies
      6. Mexico
        1. Small Molecules
        2. Biologics
        3. Intramuscular
        4. Subcutaneous
        5. Central Nervous System Disorders
        6. Infectious Diseases
        7. Metabolic & Endocrine Disorders
        8. Oncology
        9. Autoimmune & Inflammatory Diseases
        10. Other Therapeutic Areas
        11. Hospital Pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Specialty Pharmacies
      7. Argentina
        1. Small Molecules
        2. Biologics
        3. Intramuscular
        4. Subcutaneous
        5. Central Nervous System Disorders
        6. Infectious Diseases
        7. Metabolic & Endocrine Disorders
        8. Oncology
        9. Autoimmune & Inflammatory Diseases
        10. Other Therapeutic Areas
        11. Hospital Pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Specialty Pharmacies
      8. Chile
        1. Small Molecules
        2. Biologics
        3. Intramuscular
        4. Subcutaneous
        5. Central Nervous System Disorders
        6. Infectious Diseases
        7. Metabolic & Endocrine Disorders
        8. Oncology
        9. Autoimmune & Inflammatory Diseases
        10. Other Therapeutic Areas
        11. Hospital Pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Specialty Pharmacies
      9. Colombia
        1. Small Molecules
        2. Biologics
        3. Intramuscular
        4. Subcutaneous
        5. Central Nervous System Disorders
        6. Infectious Diseases
        7. Metabolic & Endocrine Disorders
        8. Oncology
        9. Autoimmune & Inflammatory Diseases
        10. Other Therapeutic Areas
        11. Hospital Pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Specialty Pharmacies
      10. Rest of LATAM
        1. Small Molecules
        2. Biologics
        3. Intramuscular
        4. Subcutaneous
        5. Central Nervous System Disorders
        6. Infectious Diseases
        7. Metabolic & Endocrine Disorders
        8. Oncology
        9. Autoimmune & Inflammatory Diseases
        10. Other Therapeutic Areas
        11. Hospital Pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Specialty Pharmacies
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.